Clinical Trial Update: Nasal High Flow Therapy for the Treatment of Respiratory Insufficiencies During Sleep [NA]

View source ↗

Summary

The clinical trial evaluating nasal high-flow therapy for sleep-disordered breathing and heart failure was terminated, and results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Sleep-disordered Breathing

Snippet

Sponsor: Fisher and Paykel Healthcare | Conditions: Sleep Disordered Breathing, Congestive Heart Failure | NA | Status: TERMINATED | Results posted: 2015-09-17